These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8974381)

  • 1. Interaction between opiate and 5-HT3 receptor antagonists in the regulation of alcohol intake.
    Le AD; Sellers EM
    Alcohol Alcohol Suppl; 1994; 2():545-9. PubMed ID: 8974381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypericum perforatum CO2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats.
    Perfumi M; Santoni M; Cippitelli A; Ciccocioppo R; Froldi R; Massi M
    Alcohol Clin Exp Res; 2003 Oct; 27(10):1554-62. PubMed ID: 14574225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT3 antagonist ICS 205-930 enhances naltrexone's effects on ethanol intake.
    Mhatre M; Pruthi R; Hensley K; Holloway F
    Eur J Pharmacol; 2004 May; 491(2-3):149-56. PubMed ID: 15140631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorsal hindbrain 5-HT3 receptors participate in control of meal size and mediate CCK-induced satiation.
    Hayes MR; Covasa M
    Brain Res; 2006 Aug; 1103(1):99-107. PubMed ID: 16793030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
    Johnson BA; Ait-Daoud N; Prihoda TJ
    Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
    Shankar RP; Karan RS; Handu SS; Bhargava VK
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined blockade of 5-HT3- and 5-HT4-serotonin receptors inhibits colonic functions in conscious rats and mice.
    Nagakura Y; Kontoh A; Tokita K; Tomoi M; Shimomura K; Kadowaki M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):284-90. PubMed ID: 9103508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining ondansetron and naltrexone treats biological alcoholics: corroboration of self-reported drinking by serum carbohydrate deficient transferrin, a biomarker.
    Ait-Daoud N; Johnson BA; Javors M; Roache JD; Zanca NA
    Alcohol Clin Exp Res; 2001 Jun; 25(6):847-9. PubMed ID: 11410720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol palatability and consumption by high ethanol-drinking rats: manipulation of the opioid system with naltrexone.
    Coonfield DL; Kiefer SW; Ferraro FM; Sinclair JD
    Behav Neurosci; 2004 Oct; 118(5):1089-96. PubMed ID: 15506891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats.
    June HL; Grey C; Warren-Reese C; Durr LF; Ricks-Cord A; Johnson A; McCane S; Williams LS; Mason D; Cummings R; Lawrence A
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2174-85. PubMed ID: 9884166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central 5-HT3 receptor stimulation by m-CPBG increases blood glucose in rats.
    Carvalho F; Macêdo D; Bandeira I; Maldonado I; Salles L; Azevedo MF; Rocha MA; Fregoneze JB; De Castro-e-Silva E
    Horm Metab Res; 2002 Feb; 34(2):55-61. PubMed ID: 11972287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
    Hayes MR; Savastano DM; Covasa M
    Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol consumption is enhanced after naltrexone treatment.
    Juárez J; Eliana Bde T
    Alcohol Clin Exp Res; 2007 Feb; 31(2):260-4. PubMed ID: 17250617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-1 and 5-HT3 receptors.
    Hayes MR; Covasa M
    Peptides; 2005 Nov; 26(11):2322-30. PubMed ID: 16269356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice.
    Middaugh LD; Kelley BM; Groseclose CH; Cuison ER
    Pharmacol Biochem Behav; 2000 Jan; 65(1):145-54. PubMed ID: 10638648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiates and alcohol self-administration in animals.
    Ulm RR; Volpicelli JR; Volpicelli LA
    J Clin Psychiatry; 1995; 56 Suppl 7():5-14. PubMed ID: 7673105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic mechanism in imipramine induced antinociception in rat tail flick test.
    Bhargava VK; Saha L
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):107-10. PubMed ID: 11211562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate and 5-HT2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide.
    Lankford MF; Myers RD
    Alcohol; 1996; 13(1):53-7. PubMed ID: 8837935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.